slides · global inventory
Plan Implementation
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 6,044
Current window 3,601-3,630
Pages 202
Rows per page 30
Slide function
3,601-3,630 of 6,044
17
The slide uses a linear timeline framework to show progression from 2015 to 2030.Genius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations 1 hit
18
The slide uses a linear process flow to illustrate the business growth strategy.Genius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations 1 hit
19
The slide uses a chevron-based timeline structure to map out annual milestones from 2023 to 2027.Genius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations 1 hit
21
The slide uses a grid of icons to summarize five distinct corporate initiatives.Genius Group | Investor Presentation Deck | 29 slides · Genius Group
Pitch deck Investor relations 1 hit
10
Uses a process flow diagram to illustrate the evolution from current commercial use to future expansion.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
16
Includes FDA approval precedents in the footer to establish credibility.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
18
The slide uses a two-column layout to separate milestones by drug candidate.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
31
Includes FDA approval precedents in the footer.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
32
The diagram illustrates a classic dose-escalation study design.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
43
Includes logos for BeiGene and Novartis at the bottom.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
05
The slide uses a Gantt-style chart to show the progress of various drug candidates.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
07
The slide uses a simple list format to highlight two key upcoming clinical milestones.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
The slide uses a timeline-based diagram to illustrate the clinical trial protocol.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · Traction1 hit
17
The slide uses a process-oriented layout to describe the regulatory and commercialization pathway.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
18
The slide outlines the strategic rationale for a specific clinical trial phase.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
19
The slide outlines a clinical trial design (MMED007) using a timeline-based visualization.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
20
MindMed | Investor Presentation Deck | 32 slidesMindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
08
The slide outlines specific milestones including FDA approval, manufacturing scale-up, US market entry, and D2C expansion.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations Beat · ProductLoop · Logic Chain1 hit
12
Nemaura Medical | Investor Presentation Deck | 22 slidesNemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
13
Nemaura Medical | Investor Presentation Deck | 22 slidesNemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
14
Nemaura Medical | Investor Presentation Deck | 22 slidesNemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
15
The superscript 3 in '2000^3' appears to be a typo or formatting error in the source slide.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
19
The slide uses a numbered list format to present future product roadmap items.Nemaura Medical | Investor Presentation Deck | 22 slides · Nemaura Medical
Pitch deck Investor relations 1 hit
07
The slide uses a Gantt-style chart to visualize clinical trial progress for seven distinct programs.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
16
The diagram illustrates a decision-tree process based on clinical trial outcomes.Neumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
28
Neumora Therapeutics | IPO Presentation Deck | 32 slidesNeumora Therapeutics | IPO Presentation Deck | 32 slides · Neumora Therapeutics
Pitch deck Investment bank 1 hit
03
This is a standard IPO/follow-on offering summary table.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
06
The slide uses a Gantt-style visualization for drug development stages.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank 1 hit
16
The slide uses a process-oriented layout to show the transition between trial phases.RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Beat · SolutionLoop · Hypothesis Test1 hit
21
The slide uses a standard clinical trial flow diagram (Population -> Treatment -> Endpoints -> Crossover).RayzeBio | IPO Presentation Deck | 41 slides · RayzeBio
Pitch deck Investment bank Loop · Hypothesis Test1 hit